These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30476583)

  • 1. Liver Fat Is Associated With Markers of Inflammation and Oxidative Stress in Analysis of Data From the Framingham Heart Study.
    Fricker ZP; Pedley A; Massaro JM; Vasan RS; Hoffmann U; Benjamin EJ; Long MT
    Clin Gastroenterol Hepatol; 2019 May; 17(6):1157-1164.e4. PubMed ID: 30476583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study.
    Pou KM; Massaro JM; Hoffmann U; Vasan RS; Maurovich-Horvat P; Larson MG; Keaney JF; Meigs JB; Lipinska I; Kathiresan S; Murabito JM; O'Donnell CJ; Benjamin EJ; Fox CS
    Circulation; 2007 Sep; 116(11):1234-41. PubMed ID: 17709633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic steatosis and cardiovascular disease outcomes: An analysis of the Framingham Heart Study.
    Mellinger JL; Pencina KM; Massaro JM; Hoffmann U; Seshadri S; Fox CS; O'Donnell CJ; Speliotes EK
    J Hepatol; 2015 Aug; 63(2):470-6. PubMed ID: 25776891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relations of liver fat with prevalent and incident chronic kidney disease in the Framingham Heart Study: A secondary analysis.
    Wilechansky RM; Pedley A; Massaro JM; Hoffmann U; Benjamin EJ; Long MT
    Liver Int; 2019 Aug; 39(8):1535-1544. PubMed ID: 31033142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study.
    Weinstein G; Zelber-Sagi S; Preis SR; Beiser AS; DeCarli C; Speliotes EK; Satizabal CL; Vasan RS; Seshadri S
    JAMA Neurol; 2018 Jan; 75(1):97-104. PubMed ID: 29159396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Liver Fat and Bone Density is Confounded by General and Visceral Adiposity in a Community-Based Cohort.
    Li BT; Simon TG; Wang N; Chung RT; Corey KE; Dichtel LE; Samelson EJ; Kiel DP; Long MT
    Obesity (Silver Spring); 2021 Mar; 29(3):595-600. PubMed ID: 33528915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart study.
    Long MT; Wang N; Larson MG; Mitchell GF; Palmisano J; Vasan RS; Hoffmann U; Speliotes EK; Vita JA; Benjamin EJ; Fox CS; Hamburg NM
    Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1284-91. PubMed ID: 25745056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple clinical model predicts incident hepatic steatosis in a community-based cohort: The Framingham Heart Study.
    Long MT; Pedley A; Massaro JM; Hoffmann U; Ma J; Loomba R; Chung RT; Benjamin EJ
    Liver Int; 2018 Aug; 38(8):1495-1503. PubMed ID: 29377504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dietary fat and saturated fat content on liver fat and markers of oxidative stress in overweight/obese men and women under weight-stable conditions.
    Marina A; von Frankenberg AD; Suvag S; Callahan HS; Kratz M; Richards TL; Utzschneider KM
    Nutrients; 2014 Oct; 6(11):4678-90. PubMed ID: 25353663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular inflammation and sleep disordered breathing in a community-based cohort.
    Chami HA; Fontes JD; Vasan RS; Keaney JF; O'Connor GT; Larson MG; Benjamin EJ; Gottlieb DJ
    Sleep; 2013 May; 36(5):763-768C. PubMed ID: 23633759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple inflammatory biomarkers in relation to cardiovascular events and mortality in the community.
    Schnabel RB; Yin X; Larson MG; Yamamoto JF; Fontes JD; Kathiresan S; Rong J; Levy D; Keaney JF; Wang TJ; Murabito JM; Vasan RS; Benjamin EJ
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1728-33. PubMed ID: 23640499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical correlates of change in inflammatory biomarkers: The Framingham Heart Study.
    Fontes JD; Yamamoto JF; Larson MG; Wang N; Dallmeier D; Rienstra M; Schnabel RB; Vasan RS; Keaney JF; Benjamin EJ
    Atherosclerosis; 2013 May; 228(1):217-23. PubMed ID: 23489346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relations of Liver Fat With Prevalent and Incident Atrial Fibrillation in the Framingham Heart Study.
    Long MT; Yin X; Larson MG; Ellinor PT; Lubitz SA; McManus DD; Magnani JW; Staerk L; Ko D; Helm RH; Hoffmann U; Chung RT; Benjamin EJ
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28465298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pericardial fat volume correlates with inflammatory markers: the Framingham Heart Study.
    Tadros TM; Massaro JM; Rosito GA; Hoffmann U; Vasan RS; Larson MG; Keaney JF; Lipinska I; Meigs JB; Kathiresan S; O'Donnell CJ; Fox CS; Benjamin EJ
    Obesity (Silver Spring); 2010 May; 18(5):1039-45. PubMed ID: 19875999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between hepatic steatosis and incident cardiovascular disease, cancer, and all-cause mortality in a US multicohort study.
    Ahmed HS; Wang N; Carr JJ; Ding J; Terry JG; VanWagner LB; Hou L; Huo Y; Palmisano J; Zheng Y; Benjamin EJ; Long MT
    Hepatology; 2023 Jun; 77(6):2063-2072. PubMed ID: 36651168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body mass index and the visceral adipose tissue expression of IL-6 and TNF-alpha are associated with the morphological severity of non-alcoholic fatty liver disease in individuals with class III obesity.
    Jorge ASB; Andrade JMO; Paraíso AF; Jorge GCB; Silveira CM; de Souza LR; Santos EP; Guimaraes ALS; Santos SHS; De-Paula AMB
    Obes Res Clin Pract; 2018; 12(Suppl 2):1-8. PubMed ID: 27083404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress and inflammatory markers in relation to circulating levels of adiponectin.
    Gustafsson S; Lind L; Söderberg S; Zilmer M; Hulthe J; Ingelsson E
    Obesity (Silver Spring); 2013 Jul; 21(7):1467-73. PubMed ID: 23585283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study.
    McKimmie RL; Daniel KR; Carr JJ; Bowden DW; Freedman BI; Register TC; Hsu FC; Lohman KK; Weinberg RB; Wagenknecht LE
    Am J Gastroenterol; 2008 Dec; 103(12):3029-35. PubMed ID: 18853970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and its association with cardiovascular disease.
    Vanjiappan S; Hamide A; Ananthakrishnan R; Periyasamy SG; Mehalingam V
    Diabetes Metab Syndr; 2018 Jul; 12(4):479-482. PubMed ID: 29402657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study.
    Foster MC; Hwang SJ; Porter SA; Massaro JM; Hoffmann U; Fox CS
    Hypertension; 2011 Nov; 58(5):784-90. PubMed ID: 21931075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.